NEVRO CORP. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2018-11-05: Form 8-K; Period of report 2018-11-05; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2018-08-02: Form 8-K; Period of report 2018-08-02; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2018-07-30: Form 8-K; Period of report 2018-07-30; Description 8.01 Other Events; Details 8.01.
- 2018-07-25: Form 8-K; Period of report 2018-07-24; Description 8.01 Other Events; Details 8.01.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2018-11-05 | 8-K | 2018-11-05 | 2.02 Results of Operations and Financial Condition | 2.02 On November 5, 2018, Nevro Corp. (“Nevro” or the “Company”) issued a press release relating to its financial results for the three and nine months ended September 30, 2018. | nvro-8k_20181105.htm |
| 2018-08-02 | 8-K | 2018-08-02 | 2.02 Results of Operations and Financial Condition | 2.02 On August 2, 2018, Nevro Corp. (“Nevro” or the “Company”) issued a press release relating to its financial results for the three and six months ended June 30, 2018. | nvro-8k_20180802.htm |
| 2018-07-30 | 8-K | 2018-07-30 | 8.01 Other Events | 8.01 On July 30, 2018, Nevro Corp. issued a press release announcing that it has filed, with Boston Scientific Corporation, a joint statement proposing dismissal of the declaratory judgment claims that remain outstanding in the parties’ patent dispute the United States District Court for the Northern District of California (Case No. 16-cv-06830-VC). | d594234d8k.htm |
| 2018-07-25 | 8-K | 2018-07-24 | 8.01 Other Events | 8.01 On July 25, 2018, Nevro Corp. (“Nevro” or the “Company”) issued a press release announcing that the United States District Court for the Northern District of California issued an order on claim construction and summary judgment in the Company’s patent litigation with Boston Scientific Corporation, et al., on July 24, 2018 (Case No. 16-cv-06830-VC). | d581608d8k.htm |
| 2018-07-16 | 8-K | 2018-07-16 | 2.02 Results of Operations and Financial Condition | 2.02 On July 16, 2018, Nevro Corp. (“Nevro” or the “Company”) issued a press release announcing its preliminary unaudited revenue for the second quarter ended June 30, 2018. | nvro-8k_20180716.htm |
| 2018-07-13 | 8-K | 2018-07-09 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On July 9, 2018, Nevro Corp. (the “Company”) determined to terminate James Alecxih’s, Vice President Worldwide Sales, employment with the Company. | d431108d8k.htm |
| 2018-05-25 | 8-K | 2018-05-21 | 5.07 Submission of Matters to a Vote of Security Holders | 5.07 On May 21, 2018, Nevro Corp. (the “Company”) held its Annual Meeting of Stockholders (the “Annual Meeting”). | nvro-8k_20180521.htm |
| 2018-05-07 | 8-K | 2018-05-07 | 2.02 Results of Operations and Financial Condition | 2.02 On May 7, 2018, Nevro Corp. (“Nevro” or the “Company”) issued a press release relating to its financial results for the three months ended March 31, 2018. | nvro-8k_20180507.htm |
| 2018-02-22 | 8-K | 2018-02-22 | 2.02 Results of Operations and Financial Condition | 2.02 On February 22, 2018, Nevro Corp. (“Nevro” or the “Company”) issued a press release relating to its financial results for the three months and full year ended December 31, 2017. | nvro-8k_20180222.htm |
| 2018-01-08 | 8-K | 2018-01-08 | 2.02 Results of Operations and Financial Condition | 2.02 On January 8, 2018, Nevro Corp. issued a press release announcing its preliminary unaudited revenue for the fourth quarter and year ended December 31, 2017 and its expectations for worldwide revenue for the full year 2018. | nvro-8k_20180108.htm |